a significant trendp < 0.001
Clinical Outcomes of Patients Who Received Non-Targeted First-Line Therapy For second-line TTD, there was a significant trend ( p < 0.001) among the four cohorts ( Figure 3 A).
Clinical Outcomes of Patients Who Received Non-Targeted First-Line Therapy For second-line TTD, there was a significant trend ( p < 0.001) among the four cohorts ( Figure 3 A).